Glow LifeTech Launches Two Cannabis Consumer Brands, MOD and .decimal, Featuring Its Rapid Onset Liquid and Powder Ingredient Technologies
Toronto, Ontario--(Newsfile Corp. - August 2, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the launch of two cannabis consumer brands in Canada, MOD and .decimal, with both featuring Glow's portfolio of proprietary liquid and powder cannabis ingredient technologies. MOD is a brand of naturally flavoured water-soluble drops and .decimal is a brand of precision-dosed, fast-acting capsules. Commercial sales activities have...
2023-08-02 5:00 PM EDT
Glow Expedites Path to Commercialization with the Upcoming Launch of Multiple In-House Cannabis Consumer Brands
Toronto, Ontario--(Newsfile Corp. - July 27, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the upcoming launch of multiple in-house cannabis consumer brands powered by its portfolio of proprietary ingredient technologies. The Company expects to commercially deploy its innovative technology and products into the Canadian cannabis market as early as Q3 2023. "By launching our own in-house CPG brands and products, we are...
2023-07-27 5:49 PM EDT
Glow Expands Technology Portfolio and Proprietary Product Format Capabilities; Develops New Water-Soluble Cannabis Powder Technology
Toronto, Ontario--(Newsfile Corp. - July 6, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce that it has developed a proprietary, water-soluble cannabis powder technology ("New Powder Technology''), which expands the Company's technology portfolio to both liquid and powder cannabinoid ingredients and unlocks a new range of product format...
2023-07-06 6:34 PM EDT
Glow Completes Successful Pilot Production of Proprietary MyCell Liquid Cannabis Ingredients and Adds Multiple New Cannabinoids to Portfolio
Toronto, Ontario--(Newsfile Corp. - June 28, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to report that it has further accelerated its path to commercialization following its successful pilot-scale production of MyCell® water-soluble cannabis ingredients and the expansion of its cannabis ingredient portfolio with the development of MyCell® CBN and CBG...
2023-06-28 8:23 PM EDT
Glow Launches New Brand Identity to Underscore Its High-Performance, Technology-Driven Portfolio of Natural Ingredients
Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce the unveiling of its new brand identity going live today. As the Company advances its commercial plans, Glow is introducing a full top-to-bottom redesign of its logo, colour palette, packaging, marketing materials, and launching a new website,...
2023-03-21 5:00 PM EDT
Glow LifeTech Completes Development of Proprietary MyCell Liquid Cannabis Ingredients; Advances Plans to Launch in Canadian Market
Toronto, Ontario--(Newsfile Corp. - November 1, 2022) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce the completion of development of its proprietary MyCell® liquid cannabis ingredients, including THC and CBD. The Company now plans for commercialization in the Canadian market, given product readiness. The successful development of MyCell® liquid...
2022-11-01 5:00 PM EDT
Glow LifeTech Reports Positive Preliminary Results from Clinical Study of Artemic Support(R) on Patients with Long COVID Syndrome
Clinical Study results indicate the potential ability of Glow Lifetech's ArtemiC Support® to reduce symptoms of Post-Acute COVID Syndrome (Long COVID).Study results demonstrate the statistically significant reduction in severity of a range of Long COVID symptoms, including Dyspnea (shortness of breath), Cough, Asthenia (physical weakness/lack of energy), Headache and Mental Confusion.150 Patients were administered ArtemiC Support® during a 6-week period under the supervision of their doctor,...
2022-07-18 8:46 PM EDT
Glow Announces Extension of Warrant Expiry
Toronto, Ontario--(Newsfile Corp. - July 14, 2022) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), is pleased to announce that it has extended the expiry date of an aggregate of 8,569,217 previously issued warrants (the "Warrants"). The Warrants were originally issued by the Company on March 3, 2021 at an exercise price of $0.40 per common share. The Warrants have been extended for an additional two (2) years, with the amended expiry being March...
2022-07-14 4:05 PM EDT
Glow Provides Update on Cannabis Development Activities and Ongoing Clinical Studies
Toronto, Ontario--(Newsfile Corp. - July 7, 2022) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), is pleased to provide an update on commercial operations, cannabis-related development activities and clinical studies related to its proprietary MyCell®-enhanced products. Glow is now focused on the final stages of development of proprietary CBD (cannabidiol) and THC1 (tetrahydrocannabinol) water-soluble ingredients in preparation for launch in Canada. With...
2022-07-07 4:00 PM EDT
Glow Completes Reactor Commissioning and Initiates Development of Proprietary MyCell(R) Water-Soluble Cannabis Ingredients
Toronto, Ontario--(Newsfile Corp. - January 11, 2022) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce it has completed the commissioning of its reactor production equipment and initiated development of its high-performance, water-soluble MyCell® cannabis ingredients at its Canadian processing facility. MyCell® technology also powers Artemic Support®,...
2022-01-11 3:00 AM EST
Glow Appoints Scientific & Regulatory Expert Advisors to Advance Commercial Activities
Toronto, Ontario--(Newsfile Corp. - December 29, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to welcome scientific and regulatory experts Scott Sawler, Dr. Murray Berall and Dr. Melissa Lewis-Bakker and as the initial appointees to the Company's Technical Advisory Board. The three advisors will provide counsel and guidance on the technical, regulatory...
2021-12-29 4:00 PM EST
Glow LifeTech Announces Commencement of Clinical Study of Artemic Support Featuring MyCell Technology on Patients with Long COVID
Toronto, Ontario--(Newsfile Corp. - December 24, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce that it is co-sponsoring a clinical study (the "Study") to assess the impact of its proprietary natural health product Artemic Support®, which features MyCell® Technology, in patients with Long COVID syndrome.Post-acute COVID syndrome (PACS) or...
2021-12-24 1:00 PM EST
Glow Completes Buildout of Canadian Facility and Begins Commissioning Proprietary Reactor
Toronto, Ontario--(Newsfile Corp. - November 9, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce it has completed the buildout of its licensed processing space ("Processing Space") in Canada and has begun commissioning its reactor production equipment which enables the production of its high-performance MyCell® ingredients. Glow has completed...
2021-11-09 3:00 AM EST
Glow LifeTech Reports Positive Preclinical Data on Proprietary MyCell CBD Demonstrating Superior Bioavailability and Rapid Onset Time
Toronto, Ontario--(Newsfile Corp. - November 4, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to report positive results from a preclinical pharmacokinetic study evaluating its advanced MyCell® CBD concentrate against traditional CBD oil. Overall, MyCell® CBD formulation demonstrated fast-acting absorption in under 15 minutes and 13x greater...
2021-11-04 5:00 PM EDT
Glow Engages Regulatory Consultant Firms to Advance Commercialization of Artemic(TM) and Other Nutraceutical Ingredients in U.S. and Mexico
Toronto, Ontario--(Newsfile Corp. - October 27, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce that it has engaged KGK Science (KGK) and Fryer Inc. (Fryer) as two outside regulatory consultants to support commercialization efforts for Artemic™ and other MyCell® technology ingredients in U.S. and Mexico markets. Glow has engaged the regulatory...
2021-10-27 3:00 AM EDT
Glow Takes Receipt of MyCell Reactor for Prototyping and Formulation for Canadian Processing; Receives CSA Standards Approval
Toronto, Ontario--(Newsfile Corp. - October 25, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce it has received its first reactor equipment, for production of its high-performance MyCell® ingredients, and successfully received CSA standards approval.The receipt of the reactor in Canada and receiving CSA standards approval will allow Glow to...
2021-10-25 4:03 PM EDT
Glow LifeTech Strengthens Management Team with Manufacturing and Product Development Leaders; Provides Management Overview
Toronto, Ontario--(Newsfile Corp. - October 14, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide an update on new appointments to support the Company's advancing manufacturing and commercial initiatives including the appointment of Josh Bald, CPA as Glow's dedicated CFO. As with many industries, Glow's setup of manufacturing and production related operations have been delayed due to supply shortages stemming from the COVID-19...
2021-10-14 3:46 PM EDT
Glow LifeTech Announces Upgrade to OTCQB Under Ticker 'GLWLF'
Toronto, Ontario--(Newsfile Corp. - August 16, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce that after successfully completing the application process, the Company has received approval from OTC Markets Group Inc. for its common shares to begin trading on the OTCQB Market ("OTCQB") under the symbol "GLWLF". The Company's common...
2021-08-16 8:56 PM EDT
Glow Acquires Strategic Equity Investment in Nova Mentis
Toronto, Ontario--(Newsfile Corp. - August 10, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce a strategic investment into Nova Mentis1 ("Nova").The Company purchased 854,000 shares in Nova at an average cost of $0.12 CAD.Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and...
2021-08-10 9:45 PM EDT
Glow LifeTech Secures Canadian Processing Facility, Begins Build-out to Produce Next-Generation Cannabis Ingredients
Toronto, Ontario--(Newsfile Corp. - May 28, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to report that the Company has commenced the build-out and commissioning of licensed processing space ("Processing Space") to bring a suite of fast-acting, high-absorption, water-soluble cannabis-based ingredients to the Canadian market. The Processing Space is licensed for the...
2021-05-28 3:00 AM EDT